BioCentury
ARTICLE | Company News

Bio-Quant, Dompe chemokine deal

December 10, 2001 8:00 AM UTC

The companies will identify drug candidates against four chemokine receptors, including IL-8, related to inflammatory and immune diseases, such as atherosclerosis, glomerulonephritis, asthma and aller...